CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
Prednisone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02748070
NCT02748070N/ACompleted

The Role of Perioperative Systemic Steroids in Patients With Chronic Rhinosinusitis Without Polyps (CRSsNP)

Stanford University·interventional·Posted Apr 22, 2016·Updated Aug 4, 2020

In Brief

A clinical study evaluating Prednisone and Flonase for Chronic Rhinosinusitis and 3 related conditions. Completed, enrolled 81 participants across 1 site.

Detailed Summary

While oral steroids have been shown to be effective in the management of patients with chronic rhinosinusitis with polyps, its role in treating chronic rhinosinusitis without polyps (CRSsNP) is ambiguous. Despite a lack of strong clinical evidence to suggest a benefit in this disease state, steroids are often prescribed as a component of post-operative care after sinus surgery for patients without polyps. Oral steroids carry with them significant adverse effects, and should be prescribed thoughtfully. The aims of this study are to determine if oral steroids in the peri-operative period improves patient outcomes in CRS without polyps.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 22, 2016
Enrollment StartAug 1, 2015
Primary CompletionJul 15, 2019
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 10.2 years ago

Interventions

Prednisonedrug

Flonasedrug